Drawing for TAHEEBO NFD

USPTO serial 79009271

TAHEEBO NFD

Reviewed by CopyMark Law Group

Reg. 3083042Status 706Registered
Filing date
Status date
Registration date
Apr 18, 2006
Examiner
OLANDRIA, WARREN
Law office
Historical data usage

What this means

This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.

Need help with TAHEEBO NFD?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

M. Scott Alprin

M. Scott Alprin Alprin Law Offices, P.C.5 Pinehurst Circle, N.W.Washington, DC 20015United States

Goods and services

ClassDescriptionStatusFirst use
005[ Pharmaceutical preparations for the prevention of blood platelet cohesion; anti-cancer preparations; tumor suppressing agents; cancer prophylactics; antipyretics; analgesics; antipruritics; anti-protozoan preparations; astringents; pharmaceutical styptic preparations; anti-inflammatory preparations; antitussive compounds; expectorants; preparations for treating colds; pharmaceutical anti-allergic preparations and substances; skin emollients for medical purposes; dermatological preparations; medicated hair care preparations; ophthalmic preparations; cardio-tonics; diuretics; antidotes; anti-hypertensive medications; hemostats; anti-coagulants; anti-diarrhea medications; intestinal treatment preparations; digestants; evacuants; purgatives; antacids; enema preparations; cholagogues; pharmaceutical preparations for the treatment of rheumatism, gout, diabetes, infectious dermatosis, cutaneous ulcer, peptic ulcer, hyperlipemia, hemorrhoids, Parkinsons diseases, ischemic heart disease, kidney disease, circulatory disorders, urinary disorders, genital organ disorders; all purpose disinfectant anti-microbial preparations; agents against anti-fast bacteria; fungistats; anti-parasitic preparations; biological preparations for medical purposes; reagents for medical purposes; medical diagnostic reagents ]SECTION 71 - CANCELLED—
029[ Tofu, namely, bean curds; natto, namely, steamed and fermented soybeans; processed soybeans; processed eggs; soup preparations ]SECTION 71 - CANCELLED—
030Tea; [ coffee; cocoa; coffee substitutes; tea-based beverages with fruit flavoring; coffee-based beverages; cocoa-based beverages with milk; bread; cakes; pastries; confectionery, namely, crystallized sugar pieces, jellies, chocolates, candy, nougat, chewing gum, gum drops, chips, caramel and cookies; mixes for ice cream; powders for ice cream; sherbet mixes; powders for sherbets; ] dietary and nutritional supplements in the form of powder, granule, capsule or tablet, main ingredient of which is bark of Tabebuia trees; [ curry mixes; stew mixes, namely, thickening agents for use in cooking stews; roux, namely, flour and fat cooked together and used as a thickener in the form of powder, granule, paste or cake for making curry; roux, namely, flour and fat cooked together and used as a thickener in the form of powder, granule, paste or cake for making stew ]ACTIVE—
032[ Beer; soft drinks; fruit juice; whey beverages; vegetable juice; powders used in the preparation of non-alcoholic beverages, namely, soft drinks ]SECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 27, 2026NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
Jul 27, 202671AGREGISTERED-SEC.71 ACCEPTED—
Jul 27, 2026APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
May 7, 2026ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Apr 1, 2026ES71TEAS SECTION 71 RECEIVED—
Apr 18, 2025REM4COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED—
Sep 6, 2024NREPNEW REPRESENTATIVE AT IB RECEIVED—
Aug 22, 2024RNWLINTERNATIONAL REGISTRATION RENEWED—
Mar 29, 2019WOAGWITHDRAWAL OF ATTORNEY GRANTED—
Mar 29, 2019WOARTEAS WITHDRAWAL OF ATTORNEY RECEIVED—
Feb 16, 2017INNAINVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE—
Dec 12, 2016INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
Apr 12, 2016NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
Apr 12, 201671AGREGISTERED-SEC.71 ACCEPTED—
Apr 7, 2016ES71TEAS SECTION 71 RECEIVED—
Nov 3, 2014LIMNLIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED—
Oct 23, 2014RNWLINTERNATIONAL REGISTRATION RENEWED—
Oct 16, 2014LIMGLIMITATION OF GOODS RECEIVED FROM IB—
May 1, 2014INNPPARTIAL INVALIDATION PROCESSED BY THE IB—
Apr 1, 2014INPSPARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
May 13, 2013INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
Sep 13, 2012NA75NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - MAILED—
Sep 13, 2012C75PREGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.—
Sep 13, 2012715FREGISTERED - SEC. 71 & SEC. 15 FILED—
Sep 13, 2012APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Aug 13, 2012ES75TEAS SECTION 71 & 15 RECEIVED—
Nov 25, 2007FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Dec 28, 2006LIMGLIMITATION OF GOODS RECEIVED FROM IB—
Nov 21, 2006FICSFINAL DISPOSITION NOTICE SENT TO IB—
Nov 21, 2006FIMPFINAL DISPOSITION PROCESSED—
Nov 3, 2006FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Apr 18, 2006R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 17, 2006CHPBPOST PUBLICATION AMENDMENT - ENTERED—
Jan 25, 2006FAXXFAX RECEIVED—
Jan 24, 2006PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 4, 2006NPUBNOTICE OF PUBLICATION—
Dec 8, 2005PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Dec 8, 2005ALIEASSIGNED TO LIE—
Nov 10, 2005CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 28, 2005ACECAMENDMENT FROM APPLICANT ENTERED—
Oct 28, 2005ALIEASSIGNED TO LIE—
Oct 28, 2005TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 20, 2005CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 20, 2005TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 17, 2005CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 17, 2005TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 17, 2005TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jun 2, 2005RFNTREFUSAL PROCESSED BY IB—
Apr 18, 2005CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 16, 2005CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 8, 2005DOCKASSIGNED TO EXAMINER—
Apr 8, 2005NWAPNEW APPLICATION ENTERED—
Apr 7, 2005REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance